文献速递MDS 与骨髓增殖性肿瘤白血病

Bcor功能不足促进骨髓增生异常综合征的发生与进展

Bcor insufficiency promotes initiation and progression of myelodysplastic syndrome.
PubMed 文献 · Blood · 2018-09-18

研究分析缺失Bcor外显子9和10的小鼠(Bcor ΔE9-10/y),该突变表达的BCOR羧基端截短蛋白不能与多梳抑制复合物1.1的核心效应组分相互作用。Bcor ΔE9-10/y小鼠发生致死性T-ALL,其造血细胞在髓系区室显示生长优势;同时缺失Tet2后(Tet2 Δ/Δ Bcor ΔE9-10/y)小鼠发生致死性MDS,表现为进行性贫血和白细胞减少、无效造血及血细胞形态学发育异常。

要点

  • Bcor ΔE9-10/y小鼠发生致死性T-ALL,类似Bcor ΔE4/y小鼠。
  • Bcor ΔE9-10/y造血细胞在髓系区室显示生长优势,合并Tet2缺失后增强。
  • Tet2 Δ/Δ Bcor ΔE9-10/y小鼠发生致死性MDS,伴贫血、白细胞减少和形态学发育异常。

核心结论

  • 结果揭示BCOR在髓系恶性肿瘤中具有抑癌功能,并强调Bcor功能不足对MDS发生和进展的影响。

研究设计与样本

  • 分析缺失Bcor外显子9和10的小鼠(Bcor ΔE9-10/y),该突变表达不能与多梳抑制复合物1.1核心效应组分相互作用的羧基端截短BCOR。
  • 构建Tet2 Δ/Δ Bcor ΔE9-10/y小鼠,并将MDS细胞移植至二次受体。

主要发现

  • Bcor ΔE9-10/y小鼠发生致死性T-ALL,方式与Bcor ΔE4/y小鼠相似。
  • Bcor ΔE9-10/y造血细胞在髓系区室显示生长优势,同时缺失Tet2后该优势进一步增强。
  • Tet2 Δ/Δ Bcor ΔE9-10/y小鼠发生致死性MDS,表现为进行性贫血和白细胞减少、无效造血及血细胞形态学发育异常。
  • Tet2 Δ/Δ Bcor ΔE9-10/y MDS细胞在二次受体中重现MDS或演变为致死性MDS/骨髓增殖性肿瘤。
  • 转录谱显示Bcor ΔE9-10/y祖细胞中Cebp家族和Hoxa簇髓系调节基因去抑制,MDS红系母细胞中p53靶基因激活并发生大量凋亡。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BCOR, encoding BCL-6 corepressor (BCOR), is X-linked and targeted by somatic mutations in various hematological malignancies including myelodysplastic syndrome (MDS). We previously reported that mice lacking Bcor exon 4 (Bcor ΔE4/y ) in the hematopoietic compartment developed NOTCH-dependent acute T-cell lymphoblastic leukemia (T-ALL). Here, we analyzed mice lacking Bcor exons 9 and 10 (Bcor ΔE9-10/y ), which express a carboxyl-terminal truncated BCOR that fails to interact with core effector components of polycomb repressive complex 1.1. Bcor ΔE9-10/y mice developed lethal T-ALL in a similar manner to Bcor ΔE4/y mice, whereas Bcor ΔE9-10/y hematopoietic cells showed a growth advantage in the myeloid compartment that was further enhanced by the concurrent deletion of Tet2 Tet2 Δ/Δ Bcor ΔE9-10/y mice developed lethal MDS with progressive anemia and leukocytopenia, inefficient hematopoiesis, and the morphological dysplasia of blood cells. Tet2 Δ/Δ Bcor ΔE9-10/y MDS cells reproduced MDS or evolved into lethal MDS/myeloproliferative neoplasms in secondary recipients. Transcriptional profiling revealed the derepression of myeloid regulator genes of the Cebp family and Hoxa cluster genes in Bcor ΔE9-10/y progenitor cells and the activation of p53 target genes specifically in MDS erythroblasts where massive apoptosis occurred. Our results reveal a tumor suppressor function of BCOR in myeloid malignancies and highlight the impact of Bcor insufficiency on the initiation and progression of MDS.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Tara S, Isshiki Y, Nakajima-Takagi Y, et al. Bcor insufficiency promotes initiation and progression of myelodysplastic syndrome. Blood. 2018. PMID: 30228234. doi:10.1182/blood-2018-01-827964

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。